5N2K image
Entry Detail
PDB ID:
5N2K
Keywords:
Title:
Structure of unbound Briakinumab FAb
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2017-02-07
Release Date:
2018-01-03
Method Details:
Experimental Method:
Resolution:
2.22 Å
R-Value Free:
0.23
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Briakinumab FAb light chain
Chain IDs:A, C, E, I, K, M, P (auth: O)
Chain Length:245
Number of Molecules:7
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Briakinumab FAb heavy chain
Chain IDs:B, D, F, H, L, N, O (auth: P)
Chain Length:289
Number of Molecules:7
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Briakinumab FAb light chain
Chain IDs:G
Chain Length:245
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Briakinumab FAb heavy chain
Chain IDs:J
Chain Length:289
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12R beta 1.
Immunity 48 45 58.e6 (2018)
PMID: 29287995 DOI: 10.1016/j.immuni.2017.12.008

Abstact

Interleukin-23 (IL-23), an IL-12 family cytokine, plays pivotal roles in pro-inflammatory T helper 17 cell responses linked to autoimmune and inflammatory diseases. Despite intense therapeutic targeting, structural and mechanistic insights into receptor complexes mediated by IL-23, and by IL-12 family members in general, have remained elusive. We determined a crystal structure of human IL-23 in complex with its cognate receptor, IL-23R, and revealed that IL-23R bound to IL-23 exclusively via its N-terminal immunoglobulin domain. The structural and functional hotspot of this interaction partially restructured the helical IL-23p19 subunit of IL-23 and restrained its IL-12p40 subunit to cooperatively bind the shared receptor IL-12Rβ1 with high affinity. Together with structural insights from the interaction of IL-23 with the inhibitory antibody briakinumab and by leveraging additional IL-23:antibody complexes, we propose a mechanistic paradigm for IL-23 and IL-12 whereby cognate receptor binding to the helical cytokine subunits primes recruitment of the shared receptors via the IL-12p40 subunit.

Legend

Protein

Chemical

Disease

Primary Citation of related structures